Co-Authors
This is a "connection" page, showing publications co-authored by Carlo Tascini and Davide Pecori.
Connection Strength
1.472
-
Icatibant in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Case Report. J Investig Allergol Clin Immunol. 2021 Oct 25; 31(5):451-452.
Score: 0.917
-
Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and Perspectives. J Clin Med. 2020 Jun 30; 9(7).
Score: 0.222
-
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care. J Clin Virol. 2020 08; 129:104444.
Score: 0.221
-
Covid-19 and the role of smoking: the protocol of the multicentric prospective study COSMO-IT (COvid19 and SMOking in ITaly). Acta Biomed. 2020 08 27; 91(3):e2020062.
Score: 0.056
-
Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6. J Med Virol. 2020 11; 92(11):2852-2856.
Score: 0.056